TC-83 vaccine protects against airborne or subcutaneous challenge with heterologous mouse-virulent strains of Venezuelan equine encephalitis virus

By Phillpotts R.J.   Wright A.J.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 982-988

Elsevier

Access to resources Recommend Favorite

Induction of protective immune responses against Venezuelan equine encephalitis (VEE) virus aerosol challenge with microencapsulated VEE virus vaccine

By Greenway T.E.   Eldrige J.H.   Ludwig G.   Staas J.K.   Smith J.F.   Gilley R.M.   Michalek S.M.  

Vaccine, Vol. 16, Iss. 13, 1998-08 ,pp. : 1314-1323

Elsevier

Access to resources Recommend Favorite

Monoclonal antibody protects mice against infection and disease when given either before or up to 24 h after airborne challenge with virulent Venezuelan equine encephalitis virus

By Phillpotts R.J.   Jones L.D.   Howard S.C.  

Vaccine, Vol. 20, Iss. 11, 2002-02 ,pp. : 1497-1504

Elsevier

Access to resources Recommend Favorite

Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate

By Hart M.K.   Caswell-Stephan K.   Bakken R.   Tammariello R.   Pratt W.   Davis N.   Johnston R.E.   Smith J.   Steele K.  

Vaccine, Vol. 18, Iss. 26, 2000-07 ,pp. : 3067-3075

Elsevier

Access to resources Recommend Favorite

Onset and duration of protective immunity to IA/IB and IE strains of Venezuelan equine encephalitis virus in vaccinated mice

By Hart M.K.   Lind C.   Bakken R.   Robertson M.   Tammariello R.   Ludwig G.V.  

Vaccine, Vol. 20, Iss. 3, 2001-11 ,pp. : 616-622

Elsevier

Access to resources Recommend Favorite